arrow
A

Ali Alahmari

pediatric bmt program
H指数:19
被引数:1,655

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

异基因造血细胞移植后出血性膀胱炎的发病率和结局:EBMT传染病工作组的一项调查

2026-03-260
PRE
Low-Dose Post-Transplant Cyclophosphamide in Haploidentical Stem Cell Transplantation: A Systematic Review

单倍体相合干细胞移植中低剂量移植后环磷酰胺的应用:一项系统综述

2025-12-030
PRE
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP

比较BuCy与BuCyMel作为异基因HSCT预处理方案在首次完全缓解期婴儿急性髓系白血病中的疗效:一项来自EBMT PDWP的多中心研究

2025-10-280
PRE
Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP

单份无关脐带血与未处理半相合 HCT 在儿科 AML 中的应用比较(采用 PTCy 策略):代表 EBMT PDWP 和 CTIWP 进行的回顾性研究

2025-09-290
PRE
Clinical; immunological; molecular characteristics and outcomes of stem cell transplantation in ZAP70 deficiency: a single-center experience

临床、免疫学、分子特征及ZAP70缺陷患者干细胞移植的结局:一项单中心研究

2025-09-260
OAAI
Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East

预后因素及真实世界结局:一项来自中东一家三级转诊中心的研究,该研究针对接受AYA-15方案治疗、患有费城染色体阴性急性淋巴细胞白血病(ALL)的青少年及年轻成人(AYA)进行回顾性队列研究。

2025-07-170
PRE
Outcomes of Adolescent and Young Adult (AYA) patients with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Treated with Tisagenlecleucel, real world evidence from the Middle East

中东地区接受Tisagenlecleucel治疗的复发/难治性B细胞急性淋巴细胞白血病青少年和年轻成年(AYA)患者的结局:真实世界证据

2025-07-170
PRE
Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation

建立嵌合抗原受体T细胞疗法项目:世界造血与骨髓移植网络交付框架

2025-05-230
PRE
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

正弦波形梗阻综合征/静脉闭塞病在接受伊诺妥单抗奥佐米星后接受基于全身照射的预处理进行干细胞移植的患者中的发生率:一种风险缓解策略

BLOOD
IF23.1
2024-11-050
PRE
Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

沙特阿拉伯一家三级中心中,非西方真实世界经验:Axi-Cel CAR-T在难治性/复发性B细胞淋巴瘤中的应用

BLOOD
IF23.1
2024-11-050
PRE
Real World Data of Glofitamab in Relapsed Refractory Large B-Cell Lymphoma in Non-Western Population from a Tertiary Center in Saudi Arabia

沙特阿拉伯一家三级中心非西方人群中复发难治性大B细胞淋巴瘤的Glofitamab真实世界数据

BLOOD
IF23.1
2024-11-050
PRE
Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

桥接放射治疗在抗-CD19嵌合抗原受体T细胞(CART)治疗前应用于B细胞淋巴瘤的积极结果:来自沙特阿拉伯的报告

BLOOD
IF23.1
2024-11-050
PRE
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin
2024-03-010
PRE
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source
2023-12-010
PRE
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts
2021-10-311
PRE
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia
2021-10-012
OAAI
Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium
2021-02-0117
PREAI